Discharge management after anaphylaxis

被引:3
作者
Faihs, Valentina [1 ]
Ring, Johannes [2 ]
Brockow, Knut [1 ]
Beyer, Kirsten [3 ]
Rietschel, Ernst [4 ]
Schnadt, Sabine [5 ]
Stoecker, Britta [6 ]
Treudler, Regina [7 ]
Worm, Margitta [7 ]
Klimek, Ludger [8 ]
机构
[1] Tech Univ Munich, Med Fak, Klin Dermatol & Allergol Biederstein, Munich, Germany
[2] Haut & Laserzentrum Oper, Perusastr 5, D-80333 Munich, Germany
[3] Charite Univ Med Berlin, Abt Pneumol Immunol Intens Med, Klin Padiat, Berlin, Germany
[4] Univ klinikum Koln, Zent Kinder & Jugendmed, Cologne, Germany
[5] Deutsch Allergie & Asthmabund eV DAAB, Monchengladbach, Germany
[6] Praxis Kinderheilkunde & Jugendmed, Poppelsdorfer Allee, Bonn, Germany
[7] Charite Univ Med Berlin, Klin Dermatol Venerol & Allergol, Berlin, Germany
[8] Zentrum Allergol & Rhinol Wiesbaden, Wiesbaden, Germany
关键词
anaphylaxis; discharge; emergency kit; adrenaline; allergy; training; IDIOPATHIC ANAPHYLAXIS; DRUG HYPERSENSITIVITY; CHILDREN;
D O I
10.1007/s15007-024-6371-5
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
People who have suffered anaphylaxis often suffer from far-reaching consequences in their everyday lives. Unfortunately, discharge management after successful acute treatment is often still inadequate. In order to prevent further reactions in the future and improve the quality of life of patients, a number of points must be considered and addressed or followed when the patient is discharged from acute therapy: These include a detailed medical history to identify suspected possible triggers, documentation of the acute therapy, recommendations for further allergological assessment and the prescription of an emergency self-help kit including an adrenaline auto-injector - with information and practice on how to use it, including a written emergency plan. Recommendations for avoiding highly suspected triggers and references to patient organizations are also helpful. This article is intended to provide a current overview of discharge management after successful acute treatment of anaphylaxis. Remember: "After anaphylaxis also potentially means before the next anaphylaxis".
引用
收藏
页码:16 / 25
页数:10
相关论文
共 46 条
[21]   Anaphylaxis in children and adolescents: The European Anaphylaxis Registry [J].
Grabenhenrich, Linus B. ;
Doelle, Sabine ;
Moneret-Vautrin, Anne ;
Koehli, Alice ;
Lange, Lars ;
Spindler, Thomas ;
Rueff, Franziska ;
Nemat, Katja ;
Maris, Ioana ;
Roumpedaki, Eirini ;
Scherer, Kathrin ;
Ott, Hagen ;
Reese, Thomas ;
Mustakov, Tihomir ;
Lang, Roland ;
Fernandez-Rivas, Montserrat ;
Kowalski, Marek L. ;
Bilo, Maria B. ;
Hourihane, Jonathan O'B. ;
Papadopoulos, Nikolaos G. ;
Beyer, Kirsten ;
Muraro, Antonella ;
Worm, Margitta .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (04) :1128-+
[22]   URINARY-EXCRETION OF ANGIOTENSIN-I, ANGIOTENSIN-II, ARGININE VASOPRESSIN AND OXYTOCIN IN PATIENTS WITH ANAPHYLACTOID REACTIONS [J].
HERMANN, K ;
RITTWEGER, R ;
RING, J .
CLINICAL AND EXPERIMENTAL ALLERGY, 1992, 22 (09) :845-853
[23]   Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics [J].
Hoefer, Veronika ;
Doelle-Bierke, Sabine ;
Francuzik, Wojciech ;
Rueeuroff, Franziska ;
Sabouraud-Leclerc, Dominique ;
Treudler, Regina ;
Moeser, Anne ;
Hartmann, Karin ;
Pfoehler, Claudia ;
Wagner, Nicola ;
Ensina, Luis Felipe ;
Wedi, Bettina ;
Cardona, Victoria ;
Worm, Margitta .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (01) :96-105.e8
[24]   Health-related quality of life in food and venom induced anaphylaxis and role of influencing factors [J].
Hoefer, Veronika ;
Martini, Matteo ;
Doelle-Bierke, Sabine ;
Worm, Margitta ;
Bilo, Maria Beatrice .
CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (03) :295-306
[25]   Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis [J].
Kacar, Mark ;
Rijavec, Matija ;
Selb, Julij ;
Korosec, Peter .
CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (04) :392-404
[26]   Use of omalizumab for management of idiopathic anaphylaxis A systematic review and retrospective case series [J].
Kaminsky, Lauren W. ;
Aukstuolis, Kestutis ;
Petroni, Daniel H. ;
Al-Shaikhly, Taha .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (04) :481-487
[27]   Predictors of severe and recurrent adult anaphylaxis, and gaps in the cascade of care: a retrospective, single-centre study 2009-2018 [J].
Loprete, Jacqueline ;
Montemayor, Jonathan ;
Bramah, Valerie ;
McEwan, Callum ;
Richardson, Robyn ;
Green, Jessica ;
Carr, Andrew ;
Tong, Winnie .
INTERNAL MEDICINE JOURNAL, 2024, 54 (02) :265-273
[28]   Improving adrenaline autoinjector adherence: A psychologically informed training for healthcare professionals [J].
Mahoney, Bere ;
Walklet, Elaine ;
Bradley, Eleanor ;
O'Hickey, Steve .
IMMUNITY INFLAMMATION AND DISEASE, 2019, 7 (03) :214-228
[29]   A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy [J].
Mortz, Charlotte G. ;
Parke, Louise ;
Rasmussen, Helene M. ;
Kjaer, Henrik Fomsgaard ;
Bindslev-Jensen, Carsten .
ALLERGY, 2024, 79 (04) :964-976
[30]   Adrenaline in anaphylaxis treatment and self-administration: experience from an inner city emergency department [J].
Mostmans, Y. ;
Grosber, M. ;
Blykers, M. ;
Mols, P. ;
Naeije, N. ;
Gutermuth, J. .
ALLERGY, 2017, 72 (03) :492-497